Cargando…

A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy

Gene expression network in cancer cells is orchestrated by a small number of master regulator transcription factors (MRTFs), which play a prominent role in regulating cancer intrinsic hallmarks, such as sustaining proliferative signaling, evading growth suppressors, resisting cell death, etc. A new...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinha, Uttam K., Lin, De-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091883/
https://www.ncbi.nlm.nih.gov/pubmed/37064876
http://dx.doi.org/10.7150/thno.83486
_version_ 1785023220160659456
author Sinha, Uttam K.
Lin, De-Chen
author_facet Sinha, Uttam K.
Lin, De-Chen
author_sort Sinha, Uttam K.
collection PubMed
description Gene expression network in cancer cells is orchestrated by a small number of master regulator transcription factors (MRTFs), which play a prominent role in regulating cancer intrinsic hallmarks, such as sustaining proliferative signaling, evading growth suppressors, resisting cell death, etc. A new study reports a new role of one MRTF, KLF5, in regulating tumor microenvironment in an extrinsic manner. These findings not only reveal novel mechanistic underpinnings of tumor evasion from immune destruction but also broaden our understanding of the transcriptional deregulation in cancer biology.
format Online
Article
Text
id pubmed-10091883
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-100918832023-04-13 A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy Sinha, Uttam K. Lin, De-Chen Theranostics Editorial Gene expression network in cancer cells is orchestrated by a small number of master regulator transcription factors (MRTFs), which play a prominent role in regulating cancer intrinsic hallmarks, such as sustaining proliferative signaling, evading growth suppressors, resisting cell death, etc. A new study reports a new role of one MRTF, KLF5, in regulating tumor microenvironment in an extrinsic manner. These findings not only reveal novel mechanistic underpinnings of tumor evasion from immune destruction but also broaden our understanding of the transcriptional deregulation in cancer biology. Ivyspring International Publisher 2023-03-16 /pmc/articles/PMC10091883/ /pubmed/37064876 http://dx.doi.org/10.7150/thno.83486 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Editorial
Sinha, Uttam K.
Lin, De-Chen
A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy
title A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy
title_full A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy
title_fullStr A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy
title_full_unstemmed A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy
title_short A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy
title_sort novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091883/
https://www.ncbi.nlm.nih.gov/pubmed/37064876
http://dx.doi.org/10.7150/thno.83486
work_keys_str_mv AT sinhauttamk anovelroleofmasterregulatortranscriptionfactorinantitumorimmunityandcancerimmunotherapy
AT lindechen anovelroleofmasterregulatortranscriptionfactorinantitumorimmunityandcancerimmunotherapy
AT sinhauttamk novelroleofmasterregulatortranscriptionfactorinantitumorimmunityandcancerimmunotherapy
AT lindechen novelroleofmasterregulatortranscriptionfactorinantitumorimmunityandcancerimmunotherapy